{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:36:55Z","timestamp":1789594615141,"version":"build-2803163510"},"reference-count":15,"publisher":"Elsevier BV","issue":"47","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.vaccine.2009.08.047","type":"journal-article","created":{"date-parts":[[2009,9,2]],"date-time":"2009-09-02T04:54:39Z","timestamp":1251867279000},"page":"6558-6563","source":"Crossref","is-referenced-by-count":28,"title":["CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus"],"prefix":"10.1016","volume":"27","author":[{"given":"Chunting","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"39","key":"10.1016\/j.vaccine.2009.08.047_bib1","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.1016\/j.vaccine.2008.07.026","article-title":"World wide experience with inactivated poliovirus vaccine","volume":"26","author":"Bonnet","year":"2008","journal-title":"Vaccine"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2009.08.047_bib2","first-page":"S75","article-title":"Universal use of inactivated polio vaccine","volume":"82","author":"Falleiros Carvalho","year":"2006","journal-title":"J Pediatr (Rio J)"},{"issue":"45","key":"10.1016\/j.vaccine.2009.08.047_bib3","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1016\/j.vaccine.2008.07.101","article-title":"Epidemiology of poliomyelitis\u2014options and update","volume":"26","author":"Dutta","year":"2008","journal-title":"Vaccine"},{"issue":"7034","key":"10.1016\/j.vaccine.2009.08.047_bib4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/434699a","article-title":"A global call for new polio vaccines","volume":"434","author":"Heymann","year":"2005","journal-title":"Nature"},{"issue":"15\u201316","key":"10.1016\/j.vaccine.2009.08.047_bib5","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0264-410X(98)00409-5","article-title":"Antigenic and immunogenic properties of inactivated polio vaccine made from Sabin strains","volume":"17","author":"Kersten","year":"1999","journal-title":"Vaccine"},{"issue":"6813","key":"10.1016\/j.vaccine.2009.08.047_bib6","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"issue":"6522","key":"10.1016\/j.vaccine.2009.08.047_bib7","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/374546a0","article-title":"CpG motifs in bacterial DNA trigger direct B-cell activation","volume":"374","author":"Krieg","year":"1995","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.vaccine.2009.08.047_bib8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrd2059","article-title":"Therapeutic potential of Toll-like receptor 9 activation","volume":"5","author":"Krieg","year":"2006","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"10.1016\/j.vaccine.2009.08.047_bib9","doi-asserted-by":"crossref","first-page":"944","DOI":"10.4049\/jimmunol.164.2.944","article-title":"Mechanism and function of a newly identified CpG DNA motif in human primary B cells","volume":"164","author":"Hartmann","year":"2000","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.08.047_bib10","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.4049\/jimmunol.164.3.1617","article-title":"Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo","volume":"164","author":"Hartmann","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.08.047_bib11","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hyg"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.047_bib12","first-page":"43","article-title":"Evaluation of immunostimulatory activities of human CpG-ODN containing 5\u2032-GTCGTT-3\u2032 motif in a murine model","volume":"17","author":"Xu","year":"2001","journal-title":"Chin J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.047_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/vim.2007.0079","article-title":"Effects of different immunization protocols and adjuvant on antibody responses to inactivated SARS-CoV vaccine","volume":"21","author":"Gai","year":"2008","journal-title":"Viral Immunol"},{"issue":"14","key":"10.1016\/j.vaccine.2009.08.047_bib14","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1016\/j.vaccine.2006.12.018","article-title":"The utility of ISCOMATRIX\u2122 adjuvant for dose reduction of antigen for vaccines requiring antibody responses","volume":"25","author":"Boyle","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2009.08.047_bib15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/biol.1993.1070","article-title":"Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or Sabin strains","volume":"21","author":"Sawyer","year":"1993","journal-title":"Biologicals"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09012328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09012328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T06:55:04Z","timestamp":1545029704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09012328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":15,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0264410X09012328"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.08.047","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}